Biomaterials Liability Bill Cleared For President's Signature
This article was originally published in The Gray Sheet
The "Biomaterials Access Assurance Act" (HR 872), passed by the House July 29 and the Senate July 30, is expected to be signed by President Clinton.
You may also be interested in...
Further research into biomaterials, including the development of testing methodologies, would aid device development, participants suggested at an April 9 FDA Science Board meeting held in Rockville, Maryland
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.